E-LIB Suche - Ergebnisse für: Fernández‐Fernández, Beatriz - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

MXRA5 is a TGF‐β1‐regulated human protein with anti‐inflamm..:

Poveda, Jonay ; Sanz, Ana B ; Fernandez‐Fernandez, Beatriz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192817/. , 2016

Link: http://www.ncbi.nlm.nih...

2

Mineralocorticoid receptor antagonist use in chronic kidney..:

Sarafidis, Pantelis ; Iatridi, Fotini ; Ferro, Charles...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616462/. , 2023

Link: http://www.ncbi.nlm.nih...

3

SGLT2i for evidence-based cardiorenal protection in diabeti..:

Mark, Patrick B ; Sarafidis, Pantelis ; Ekart, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615631/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Mineralocorticoid receptor antagonist use in chronic kidney..:

Sarafidis, Pantelis ; Iatridi, Fotini ; Ferro, Charles...
info:eu-repo/semantics/altIdentifier/doi/10.1093/ckj/sfad139. , 2023

Link: https://hal.univ-lorrain..

5

Atherosclerotic renovascular disease: A clinical practice d..:

Halimi, Jean-Michel ; Kreutz, Reinhold ; Januszewicz, Andrzej...
7057c5ad-a830-4756-b60a-39c209bce50c. , 2023

Link: https://doi.org/10.1093/..

6

EMPA-KIDNEY: expanding the range of kidney protection by SG..:

Fernández-Fernandez, Beatriz ; Sarafidis, Pantelis ; Soler, Maria José.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387399/. , 2023

Link: http://www.ncbi.nlm.nih...

7

EMPA-KIDNEY: expanding the range of kidney protection by SG..:

Fernandez-Fernandez, Beatriz ; Sarafidis, Pantelis ; Soler, María José.
Clinical Kidney Journal;16(8). , 2023

Link: https://hdl.handle.net/1..

8

Tirzepatide and prevention of chronic kidney disease:

Bosch, Catalina ; Carriazo Julio, Sol Maria ; Ortiz Arduan, Alberto..
Clinical Kidney Journal;16(5). , 2023

Link: https://hdl.handle.net/1..

9

SGLT2i for evidence based cardiorenal protection in diabeti..:

Mark, Patrick B ; Sarafidis, Pantelis ; Ekart, Robert...
https://eprints.gla.ac.uk/296718/2/296718.pdf. , 2023

Link: https://eprints.gla.ac.u..

10

Mineralocorticoid receptor antagonist use in chronic kidney..:

Sarafidis, Pantelis ; Iatridi, Fotini ; Ferro, Charles...
info:eu-repo/semantics/altIdentifier/doi/10.1093/ckj/sfad139. , 2023

Link: https://hal.univ-lorrain..

11

Atherosclerotic Renovascular Disease: a clinical practice d..:

Sarafidis, Pantelis A ; Theodorakopoulou, Marieta ; Ortiz, Alberto...
info:eu-repo/semantics/altIdentifier/pmid/37202218. , 2023

Link: https://hdl.handle.net/2..

12

SGLT2i for evidence based cardiorenal protection in diabeti..:

Mark, Patrick, B ; Sarafidis, Pantelis ; Ekart, Robert...
info:eu-repo/semantics/altIdentifier/doi/10.1093/ndt/gfad112. , 2023

Link: https://hal.univ-lorrain..

13

Sodium zirconium cyclosilicate and metabolic acidosis: Pote..:

Raul Fernandez-Prado ; Priscila Villalvazo ; Alejandro Avello...
http://www.sciencedirect.com/science/article/pii/S0753332222015864. , 2023

Link: https://doi.org/10.1016/..

14

SGLT2i for evidence based cardiorenal protection in diabeti..:

Mark, Patrick, B ; Sarafidis, Pantelis ; Ekart, Robert...
info:eu-repo/semantics/altIdentifier/doi/10.1093/ndt/gfad112. , 2023

Link: https://hal.univ-lorrain..

15

Mineralocorticoid receptor antagonist use in chronic kidney..:

Sarafidis, Pantelis ; Iatridi, Fotini ; Ferro, Charles...
info:eu-repo/semantics/altIdentifier/wos/WOS:001024371500001. , 2023

Link: https://hdl.handle.net/2..

1-15